Mutual Advisors, LLC Biogen Inc. Transaction History

Mutual Advisors, LLC

$3.29 Billion
Q2 2024

A detailed history of Mutual Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Mutual Advisors, LLC holds 3,530 shares of BIIB stock, worth $690,573. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,530

Previous 3,544 0.4%

Holding current value

$690,573

Previous $764,000 7.07%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$190.52 - $236.72 $2,667 - $3,314	-14 Reduced 0.4%	3,530 $818,000
Q1 2024 May 02, 2024	BUY	$212.02 - $267.71 $10,176 - $12,850	48 Added 1.37%	3,544 $764,000
Q4 2023 Jan 12, 2024	BUY	$222.59 - $267.94 $105,730 - $127,271	475 Added 15.72%	3,496 $904,000
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $164,138 - $185,256	-648 Reduced 17.66%	3,021 $776,000
Q2 2023 Jul 31, 2023	SELL	$275.25 - $318.06 $165,425 - $191,154	-601 Reduced 14.07%	3,669 $1.05 Million
Q1 2023 Apr 11, 2023	BUY	$256.56 - $292.34 $93,900 - $106,996	366 Added 9.38%	4,270 $1.19 Million
Q4 2022 Jan 12, 2023	SELL	$252.44 - $306.72 $36,603 - $44,474	-145 Reduced 3.58%	3,904 $0
Q3 2022 Nov 03, 2022	BUY	$194.69 - $268.46 $788,299 - $1.09 Million	4,049 New	4,049 $1.08 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $604,702 - $708,444	-2,489 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $181,211 - $272,768	-767 Reduced 23.56%	2,489 $609,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $59,573 - $68,784	-225 Reduced 6.46%	3,256 $924,000
Q2 2020 Aug 05, 2020	BUY	$258.66 - $342.55 $900,395 - $1.19 Million	3,481 New	3,481 $931,000
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $209,775 - $328,113	-968 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$278.5 - $352.75 $64,612 - $81,838	232 Added 31.52%	968 $291,000
Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $216,023 - $282,498	736 New	736 $260,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Advisors, LLC with notifications on news.

Account

Mutual Advisors, LLC Biogen Inc. Transaction History